VENE R.

Last name: VENE R.

2023 (v1)

Publication

Metadata-only

SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation

Costa D. Vene R. Coco S.

The p38 inhibitor SB202190 is a necessary component of the medium used for normal colorectal mucosa cultures. Sato et al. suggested that the primary activity of SB202190 may be EGFR signaling stabilization, causing an increased phosphorylation of Erk1-2 sustaining organoid proliferation. However, the growth of some colorectal cancer...

Uploaded on: February 11, 2024
2019 (v1)

Publication

Metadata-only

IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade

Pistillo M. P. Carosio R. Banelli B.

No description

Uploaded on: March 27, 2023
2020 (v1)

Publication

Metadata-only

Characterisation of innate lymphoid cell subsets infiltrating colorectal carcinoma

Carrega P. Orecchia P. Quatrini L.

No description

Uploaded on: April 14, 2023
2018 (v1)

Publication

Metadata-only

Targeting the epidermal growth factor receptor can counteract the inhibition of natural killer cell function exerted by colorectal tumor-associated fibroblasts

Costa D. Vene R. Benelli R.

Mesenchymal stromal cells (MSC) present in the tumor microenvironment [usually named tumor-associated fibroblasts (TAF)] can exert immunosuppressive effects on T and natural killer (NK) lymphocytes, favoring tumor immune escape. We have analyzed this mechanism in colorectal carcinoma (CRC) and found that co-culture of NK cells with TAF can...

Uploaded on: April 14, 2023

VENE R.

Recent uploads